Letter: programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort-more questions than answers. Authors' reply
Aliment Pharmacol Ther
.
2019 Jul;50(2):231-232.
doi: 10.1111/apt.15334.
Authors
Bernhard Scheiner
1
2
3
,
Matthias Pinter
1
2
Affiliations
1
Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
2
Liver Cancer (HCC) Study Group Vienna, Medical University of Vienna, Vienna, Austria.
3
Vienna Hepatic Hemodynamic Laboratory, Medical University of Vienna, Vienna, Austria.
PMID:
31246367
DOI:
10.1111/apt.15334
No abstract available
Publication types
Letter
Comment
MeSH terms
Apoptosis Regulatory Proteins
Carcinoma, Hepatocellular*
Humans
Immunotherapy
Liver Neoplasms*
Programmed Cell Death 1 Receptor
Substances
Apoptosis Regulatory Proteins
Programmed Cell Death 1 Receptor